(Press-News.org) CLEVELAND—Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving therapy.
In a study recently published in Molecular Imaging and Biology, the researchers describe how the breakthrough treatment targets prostate cancer cells as effectively as current therapies, but with dramatically reduced damage to salivary glands. The result: This treatment eliminates the severe dry mouth that makes eating, swallowing and speaking nearly impossible for many prostate cancer patients.
The treatment works by targeting PSMA (Prostate-Specific Membrane Antigen), a protein found in high concentrations on prostate cancer cells. Radioligand therapy (RTL) attaches radioactive material to a targeting molecule that acts like a GPS system, guiding the radiation directly to cancer cells while avoiding healthy tissue.
Current PSMA-targeted radioligand therapy is a precision cancer treatment that represents one of the most promising treatments for end-stage prostate cancer because it acts like a “smart bomb” that seeks out and destroys cancer cells.
The downside, however, is that this therapy often causes severe salivary gland damage, resulting in extreme dry mouth that can be so debilitating patients choose to stop treatment that might save their lives.
“Various strategies to mitigate this side effect have been attempted with limited success,” said James P. Basilion, professor in the Department of Biomedical Engineering at Case Western Reserve and co-leader of the Cancer Imaging Program at the Case Comprehensive Cancer Center (Case CCC).
“Our study introduced a new PSMA-targeting ligand or molecule we call PSMA-1-DOTA with more favorable binding characteristics than existing treatments,” said Xinning Wang, research associate professor in the Department of Biomedical Engineering and member of the Cancer Imaging Program at the Case CCC.
DOTA is a helper molecule that grabs onto radioactive metals and holds them tightly. This allows those metals to be connected to special targeting compounds, which can help doctors find or treat cancer more effectively.
The research demonstrated that PSMA-1-DOTA offers four times stronger binding to prostate cancer cells compared to current treatments. The treatment also significantly reduced salivary and tear gland damage, virtually eliminating the risk for dry mouth—all while offering the same tumor-fighting effectiveness of current standard radioligand therapy.
“This breakthrough could fundamentally change prostate cancer care by transforming PSMA-targeted therapy from a ‘last resort’ option to an earlier intervention,” said Zhenghong Lee, professor in the Department of Radiology and co-leader of the Cancer Imaging Program at the Case CCC.
Other treatment options are typically tried before PSMA-targeted RLT because of the severe side effects. The hope is that this new treatment could allow doctors to use this approach much earlier in a patient’s care.
The research included comprehensive testing on mouse models and in a human patient with metastatic prostate cancer at the Technical University of Munich in Germany. The patient study confirmed the lab findings, showing the new treatment avoided the salivary glands (potentially preventing dry mouth) while still finding and attacking prostate cancer cells.
The research team is now preparing for clinical trials late next year on about 12 prostate patients to validate the promising results and establish the most effective dosing procedures.
###
About Case Western Reserve University
As one of the fastest-growing research universities in the United States, Case Western Reserve University is a force in career-defining education and life-changing research. Across our campus, more than 12,000 students from around the world converge to seek knowledge, find solutions and accelerate their impact. They learn from and collaborate with faculty members renowned for expertise in medicine, engineering, science, law, management, dental medicine, nursing, social work, and the arts. And with our location in Cleveland, Ohio—a hub of cultural, business and healthcare activity—our students gain unparalleled access to academic, research, clinical and entrepreneurial opportunities that prepare them to join our network of more than 125,000 alumni worldwide. Visit case.edu to see why Case Western Reserve University is built for those driven to be a force in the world.
END
LOS ANGELES — Keck Medicine of USC has named Christian Pass chief financial officer, effective Jan. 12, 2026.
“Pass has more than 30 years of health care finance leadership experience with a proven history of cultivating high-performing teams and guiding organizations through critical financial and operational transformations,” said Rod Hanners, CEO of Keck Medicine. “He brings tremendous knowledge and skill to this position that will support the continued growth of the health system.”
As ...
PULLMAN, Wash — A low-cost, simple robotic apple picker arm developed by Washington State University researchers may someday help with fruit picking and other farm chores.
The inflatable arm can see an apple, then extend and retract to pick a piece of fruit in about 25 seconds. Weighing less than 50 pounds with its metal base, the two-foot-long arm is made of a soft fabric filled with air that is similar to, but stronger than, the wacky inflatable arm-flailing tube men that are used in outdoor advertising. The researchers in WSU’s School of Mechanical and Materials Engineering recently published their work on the robotic arm in the journal, Smart Agricultural ...
HOUSTON and BOSTON, JANUARY 7, 2026 ― The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics with MD Anderson’s clinical and scientific expertise to accelerate data-driven cancer care through new tools that can accurately analyze, interpret and translate diagnostic results into clinical practice.
As part of the collaboration, MD Anderson and SOPHiA GENETICS are launching a series of research and development programs and co-developing an advanced next-generation sequencing oncology test. Built ...
When oily plastic and glass, as well as rubber, washed onto Florida beaches in 2020, a community group shared the mystery online, attracting scientists’ attention. Working together, they linked the black residue-coated debris to a 2019 oil slick along Brazil’s coastline. Using ocean current models and chemical analysis, the team explains in ACS’ Environmental Science & Technology how some of the oily material managed to travel over 5,200 miles (8,500 kilometers) by clinging to debris.
“The research findings of our study would not have been possible without the dedication of the Friends of Palm Beach,” says Bryan James, lead author ...
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy. Despite initial responsiveness, many patients experience rapid relapse driven by cancer stem-like cells that survive chemotherapy and seed metastasis.
Addressing this unmet need, researchers led by Professor Jae Hong Seo from Korea University have discovered that pitavastatin, a widely prescribed cholesterol-lowering drug, can directly inhibit the anti-apoptotic protein Mcl-1, a key driver ...
The origin of life on Earth becomes even more fascinating and complex as we peer into the mysterious world of viruses. Said to have existed since living cells first appeared, these microscopic entities differ greatly from other forms of life. Composed of only genetic material, they lack the ability to synthesize proteins, which are essential for carrying out cellular activity and, ultimately, for life by itself.
As a result, scientists have long sought to unravel virus origins, how they evolve, and how they fit into the conventional tree of life. Professor Masaharu Takemura from ...
Cells have a remarkable housekeeping system: proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular “tag” and dismantled in the cellular recycling machinery. This process, known as the ubiquitin-proteasome system, is crucial for health and survival. Now, an international team of scientists led by CeMM, AITHYRA and the Max Planck Institute of Molecular Physiology in Dortmund has identified a new class of small molecules that harness this natural system to accelerate the removal of an immune-modulating enzyme called IDO1. The findings, published in Nature Chemistry (DOI: 10.1038/s41557-025-02021-5), introduce a new concept in ...
Research Highlights:
Light physical activity was associated with lower risk of death for adults in stages 2, 3 and 4 of cardiovascular-kidney-metabolic (CKM) syndrome, a health condition that includes heart disease, kidney disease, diabetes and obesity.
A one hour increase in light physical activity each day was associated with a 14% to 20% lower risk of death.
The association between light physical activity and lower risk of death was most pronounced for people with advanced CKM syndrome.
Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, January 7, 2026
DALLAS, ...
WASHINGTON – Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating glioblastoma, a lethal brain tumor. This approach enabled them to predict more effective treatment combinations to fight the disease on an individualized basis. This laboratory and computational research effort was led by scientists at Georgetown’s Lombardi Comprehensive Cancer Center.
“The cellular targets we identified could be key to effectively fighting a disease that has seen only one new targeted drug approved in the last two decades,” says Nagi G. Ayad, PhD, senior author, associate director for translational ...
An evidence-based web-app helped children with epilepsy to fall asleep on average 16.5 minutes earlier.
A new UK-wide clinical trial led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has evaluated a self-guided behavioural sleep programme for the parents of children with epilepsy.
The programme, which is funded by the National Institute for Health and Care Research, is called COSI (CASTLE Online Sleep Intervention) and consists of online videos and written guides based on clinically informed sleep intervention behavioural techniques.
“Sleep problems affect more than 80% ...
